The pledge comes as the United States plans to leave the international organization, The Washington Post reported.

Investigators present 48 month follow-up data from a phase 2b trial on padeliporfin vascular-targeted photodynamic therapy for intermediate-risk prostate cancer.

Investigators aimed to identify an optimal PSA cut-off to define PSA persistence after prostate cancer surgery using new ultrasensitive assay methods.

(HealthDay News) — Metabolic dysfunction-associated steatotic liver disease (MASLD) in pregnant women is a risk factor for preterm birth, according to a study published online May 9 in ...

The FDA has accepted for Priority Review the BLA for sibeprenlimab for the treatment of immunoglobulin A nephropathy in adults.

Simple stratification based on hospitalization history and diuretic use can predict outcomes for heart failure patients.

The updated warnings highlight a rare risk of heart inflammation in teen boys and young men, CBS News reported.

GLP-1RA use, but not SGLT2i or pioglitazone use, was associated with a statistically significant lower risk for dementia and cognitive impairment.

These changes are meant to limit the use of the shots while experts collect more data on how well they work for healthy people.

The president has signed an executive order stating that the US will institute a “most-favored-nation” policy, whereby the US will pay the same price for a drug as the nation that pays the lowest ...

New research suggests that outpatients with cancer are more likely than other outpatients to have antimicrobial-resistant bacterial pathogens.

Hyporesponsiveness to erythropoiesis-stimulating agents (ESAs), whether defined as lack of hemoglobin response to typical ESA doses or need for higher ESA doses to reach hemoglobi ...